Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Beta Glucan Market

  • MAR2978921
  • 209 Pages
  • April 2018
  • Pharmaceuticals
Download Sample    Get Discount   
 
Beta glucan is a natural product often found in cell walls of fungi, bacteria, yeast, algae, and cereals such as oats and barley. They are naturally occurring glucose polymers often cited as a natural immunomodulator. There are many health benefits associated with beta glucans as it helps to enhance immunity and hence recommended to people suffering from allergies, asthma, and cancer. Beta-glucans act as a catalyst to speed up the immune system response to foreign substances. They help to trigger immune system response by activating Macrophages. These cells trap and consume harmful substances which enter a human body. A beta-glucan is a form of dietary fiber and if regularly consumed significantly improves an individual's health.

End-user

End users of this technology are food and beverages industry such oats and dietary fiber products and pharmaceutical companies. Apart from this dietary fiber is often recommended to animals to enhance immunity and hence animal feed manufacturing companies also use it as raw material.

Market dynamics

The global market for beta glucan is estimated to be USD XX billion in 2016. Based on the estimations it is supposed to reach USD XX billion by 2022. The market is poised to grow due to growing health concerns and health expenditure. Beta glucan has got an application in the food industry as it helps to improve digestive health. Nowadays people monitor their daily calorie intake and cholesterol levels. Beta glucan helps in balancing fat and calorie content.

Market segmentation

The market is segmented on the basis of geography, application (food, animal feed and pharmaceuticals), and source.

Key Players

Key players in the market include Cargill, Alltech Biotechnology, Kerry Group, Tate and Lyle, Ohly and Garuda International.

Report Contents:

> Market segments

> Market Drivers, Restraints and Opportunities

> Market Size & Forecast 2016 to 2022

> Supply & Demand Value Chain

> Market - Current Trends

> Competition & Major Companies

> Technology and R&D Status

> Porters Five Force Analysis

> Strategic and Critical Success Factor Analysis of Key Players

Regional Analysis:

> North America

>> US and Canada

> Latin America

>> Mexico, Brazil, Argentina and Rest of Latin America

> Western Europe

>> EU5 (Germany, France, Italy, Spain, U.K.)

>> Nordic Countries (Denmark, Finland, Norway, and Sweden)

>> Benelux (Belgium, The Netherlands, and Luxembourg)

>> Rest of Western Europe

> Eastern Europe

>> Russia

>> Poland

>> Rest of Eastern Europe

> Asia Pacific

>> China

>> India

>> Japan

>> Australia and New Zealand

>> Rest of Asia Pacific

> Middle East and Africa

>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)

>> South Africa

>> North Africa

>> Rest of Middle East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.

Report Highlights:

> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)

> Consumer and Pricing Analysis

> Market dynamics of the industry

> Market Segmentation

> Estimated Market Sizing in terms of volume and value

> Recent trends in Market and impact

> Research Status and Technology Overview

> Extensive Industry Structure Coverage

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390